Finanza

Harvard Bioscience, Inc.: KeyBanc Capital Markets mantiene la raccomandazione Buy

Harvard Bioscience, Inc.: KeyBanc Capital Markets mantiene la raccomandazione Buy

Harvard Bioscience KeyBanc


FIMA2632# 2022-08-05T19:01:07+02:00

Show More